Výsledky vyhledávání - "Javad Vahabi"

Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular disease

Autor: Alex I. Malinin, Dan Atar, Gregory W. Barsness, Victor L. Serebruany, Javad Vahabi

Publikováno v: Journal of Human Hypertension. 22:303-310

Aliskiren, an octanamide, is nonpeptide, low molecular weight, orally active renin inhibitor effectively preventing angiotensin and aldosterone release. This drug has been recently approved for the treatment of hypertension. Considering potential lin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cc4d56bb33058fbb7e75bbf13a07825
https://doi.org/10.1038/jhh.2008.2

Zobrazit plný text záznamu

Incidence and causes of new-onset dyspnea in 3,719 patients treated with clopidogrel and aspirin combination after coronary stenting

Autor: Javad Vahabi, Wiktor Kuliczkowski, Dan Atar, Ilya Pokov, Victor L. Serebruany

Publikováno v: Thrombosis and Haemostasis. 100:314-318

SummaryThe experimental oral antiplatelet agent AZD6140 causes dyspnea in randomized trials. Whether clopidogrel may also cause dyspnea remains controversial. We sought to define the incidence and causes of dyspnea in a large post-percutaneous corona

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::685ed7eb35d28ca0c3b597a0a204d431
https://doi.org/10.1160/th08-05-0291

Zobrazit plný text záznamu

A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae

Autor: Knut Erik Hovda, Dag Jacobsen, Cathrine Lund, Javad Vahabi, Marianne Lyngra, Birgitte Stiksrud, Ivind Ekeberg, Per Drottning

Publikováno v: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol 20, Iss 1, p 49 (2012)

Objectives Changes in poisoning trends may affect both complications and outcomes in patients with acute poisoning. This study reports the treatments given and the frequency of complications, also related to treatment, mortality and sequelae related

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1110d5064e9ad6f0f59c6268b5e3d7e
https://pubmed.ncbi.nlm.nih.gov/22828054

Zobrazit plný text záznamu

Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients

Autor: Alex I. Malinin, Dan Atar, Charles H. Hennekens, Victor L. Serebruany, James J. Ferguson, Javad Vahabi

Publikováno v: Fundamentalclinical pharmacology. 22(3)

A number of antiplatelet drugs, principally aspirin alone or in combination, have been evaluated in randomized trials of survivors of prior occlusive vascular disease events or of individuals at high risk because of multiple cardiovascular risk facto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cabfd12a15ffa4ad0b2550201861f06
https://pubmed.ncbi.nlm.nih.gov/18485150

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání